aod9604 clinical trials efficacy side effects fat loss Transformative AOD-9604 Peptide Therapy AOD9604 Versus GLP1 Agonists -

Variables such as body weight, calorie intake, energy expenditure, glucose, and fat oxidation, insulin, and glycerol were measured before and after treatment with AOD9604 and hGH

No Impact on IGF-1 or Blood Sugar Levels Unlike full hGH, which can lead to increased IGF-1 and insulin resistance, AOD-9604 does not interfere with glucose metabolism

This helps reduce unnecessary agitation and supports product integrity during laboratory use

Cardiovascular and metabolic risk markers

Evidence: What does the current research actually support, and how preliminary is it

Side effects and safety profile AOD 9604 is generally well-tolerated